A study of the labetalol-induced changes in conductivity and refractoriness of the dog heart in situ.
The effect of labetalol, an alpha- and beta- adrenergic receptor blocking agent, on the electrophysiology of the dog heart in situ was studied. Pentobarbital anaesthesia which is known to increase the sympathetic tone was used. Labetalolol in doses of 0.5 to 4.0 mg.kg-1 injected intravenously caused a slight decrease in median heart rate and a slight reduction in the median conduction velocity in the atrioventricular (A-V) node in six dogs. A significant increase in the functional refractory period of the A-V node occurred at doses of 1.0 to 4.0 mg.kg-1. The functional and the effective refractory periods of the right atrium and ventricle were increased by labetalol at all doses tested. The plasma concentrations of labetalol were in the range 0.05 ot 0.8 microgram.cm-3 in five out of six dogs at the three lowest doses tested which is far below the values which could be expected to cause a membrane-stabilising effect. The alpha and beta adrenoreceptor blocking effects of labetalol on cardiac electrophysiology in vivo are discussed.
D000070:Acebutolol / Q000494:pharmacology; D000818:Animals; D001283:Atrioventricular Node / Q000187:drug effects / Q000502:physiology; D004285:Dogs; D004562:Electrocardiography; D004983:Ethanolamines / Q000494:pharmacology*; D006329:Heart Conduction System / Q000187:drug effects* / Q000502:physiology; D006339:Heart Rate / Q000187:drug effects; D007741:Labetalol / Q000097:blood / Q000494:pharmacology*
D004983:Ethanolamines; D000070:Acebutolol; D007741:Labetalol